The post Christchurch Clinical Studies Trust Announces Completion of a Clinical Study on Innovative Nicotine-Containing Product appeared first on The Center.
Smoking Cessation Feeds
Monday, September 26, 2016
Christchurch Clinical Studies Trust Announces Completion of a Clinical Study on Innovative Nicotine-Containing Product
The product prototype, designated “P3L” by the technology owner Philip Morris International, mixes nicotine with lactic acid to produce an inhalable nicotine salt aerosol with faster absorption rates than traditional nicotine replacement therapies. The d
Smoking Cessation Feeds
Smoking Cessation Feeds
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment